MEDTRONIC PLC (MDT) Stock Forecast & Price Prediction

Data as of · Health Care sector.

Forecast: StoQuant's ML model estimates a 71% probability that MEDTRONIC PLC (MDT) outperforms the S&P 500 over the next 90 trading days — a bullish signal. Wall Street's consensus 12-month price target is $98.75 from 4 analyst targets.

ML Forecast (90-day)

71% bullish

Probability of beating the S&P 500 over the next 90 trading days

Q-Score

63/100

Grade B — "Buy" composite of 140+ signals

Analyst Target

$98.75

4 targets · $95.00–$100.00

Why the model says this

The ML model scores MDT on 57 live features, trained on 5,328 labeled outcomes and walk-forward validated. Biggest drivers of today's bullish call:

Pushing the forecast up

  • Momentum63d X Sma200 Distance +0.289
  • Sector Momentum Rank +0.220
  • Industry Relative Momentum +0.076
  • Sector Relative Strength +0.053
  • Sma200 Distance +0.046

Pushing it down

  • Asset Growth Rate -0.009
  • Yield Curve Spread -0.005
  • Altman ZScore -0.005
  • Trailing PE -0.002
  • Short Term Reversal -0.002

What Wall Street is saying about MDT

Across 4 price targets published in the last 90 days (latest 2026-08-18), the consensus for MEDTRONIC PLC is $98.75 — spanning $95.00 on the low end to $100.00 on the high end.

Next-period consensus: EPS n/a (as of 2031-04-24).

Recent rating changes

Track record — don't trust a forecast without one

StoQuant publishes its full walk-forward accuracy, updated daily. Current hit rates across all scored signals:

SignalWindowHit rateAvg returnObservations
Fundamental Undervalue7d51.1%+0.50%9,340
Vc Intelligence7d50.0%+0.72%18
Volume Spike7d49.1%+0.23%6,275
Sector Momentum7d48.5%+0.02%16,414

See the full live track record → · How the model works

Peers & alternatives

Similar stocks to MDT for comparison and diversification research:

AZN researchNVS researchNVO researchSNY researchGSK research

Compare MDT vs AZN head-to-head →

More forecasts to explore

AAPL MSFT NVDA GOOGL GOOG AMZN META TSLA AVGO LLY JPM V WMT XOM UNH MA COST ORCL HD NFLX

Explore more forecasts

Discover other stocks and tools:

All forecastsFree screenerFull MDT researchProof & methodology

MDT forecast FAQ

What is the MDT stock forecast?

StoQuant's ML model estimates a 71% probability that MEDTRONIC PLC (MDT) outperforms the S&P 500 over the next 90 trading days — a bullish signal. Wall Street's consensus 12-month price target is $98.75 from 4 analyst targets.

Is MDT stock a buy or sell right now?

StoQuant's Q-Score rates MDT 63/100 (grade B, "Buy") and the 90-day ML signal is bullish at 71% probability. StoQuant publishes its full walk-forward track record at /proof — always check a forecaster's accuracy before acting.

What is the analyst price target for MDT?

The consensus analyst price target for MEDTRONIC PLC is $98.75, with a range of $95.00 to $100.00 across 4 recent analyst targets.

How accurate are StoQuant's stock forecasts?

Across StoQuant's walk-forward validated signal history, the fundamental undervalue signal hit its 7-day target in 51.1% of 9,340 observations (avg return +0.50%). Full methodology and live accuracy at /proof.

When does MDT report earnings?

MEDTRONIC PLC has no confirmed upcoming earnings date in StoQuant's data right now. Dates are confirmed by companies typically a few weeks ahead.

More stock forecasts in this sector

Technology sector forecasts

MSFT · AAPL · NVDA · GOOGL · META · TSLA · AMD · INTC · QCOM · AVGO

Large-cap diversified forecasts

BRK.B · JPM · V · MA · WMT · PG · JNJ · XOM · UNH · HD

Consumer and healthcare forecasts

COST · MCD · NFLX · DIS · PFE · ABBV · TMO · CRM · ADBE

Financial and energy forecasts

BAC · WFC · GS · MS · CVX · COP · UBER · AMAT · MU

Get MDT's forecast refreshed daily — plus the full signal stack.

ML forecasts, Q-Scores, insider clusters, and catalysts across 4,000+ tickers. Free screener.

Open the free screener Full MDT research

Additional resources

Track record · Methodology · All forecasts · MDT deep dive

Forecasts are probabilistic model outputs, not investment advice. Past accuracy does not guarantee future results.

Get the StoQuant digest — free

Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.